Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Julie Doostzadeh"'
Autor:
Julie Doostzadeh, Shadi Shokralla, Farnaz Absalan, Roxana Jalili, Sharareh Mohandessi, James W Langston, Ronald W Davis, Mostafa Ronaghi, Baback Gharizadeh
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2693 (2008)
Pyrosequencing is a DNA sequencing method based on the principle of sequencing-by-synthesis and pyrophosphate detection through a series of enzymatic reactions. This bioluminometric, real-time DNA sequencing technique offers unique applications that
Externí odkaz:
https://doaj.org/article/de2d766b03d844a1b5f8cf27e3cfe9c8
Autor:
Gregg W, Stone, Ali, Rizvi, William, Newman, Kourosh, Mastali, John C, Wang, Ronald, Caputo, Julie, Doostzadeh, Sherry, Cao, Charles A, Simonton, Krishnankutty, Sudhir, Alexandra J, Lansky, Donald E, Cutlip, Dean J, Kereiakes, S, Oxborough
Publikováno v:
New England Journal of Medicine. 362:1663-1674
Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points.We randomly as
Autor:
Alexandra J. Lansky, James B. Hermiller, Paul C. Gordon, Robert J. Applegate, Krishnankutty Sudhir, Steven B. Weinsier, Sherry Cao, Julie Doostzadeh, Gregg W. Stone
Publikováno v:
Catheterization and Cardiovascular Interventions. 75:179-186
Objective: This study evaluates the safety and efficacy of the XIENCE V® 4.0 mm stent for the treatment of de novo native coronary artery lesions. Background: In the SPIRIT III trial, the XIENCE V® everolimus-eluting stent (EES), compared with the
Autor:
Neville Kukreja, Patrick W. Serruys, Yoshinobu Onuma, Sherry Cao, Julie Doostzadeh, Susan Veldhof, Gregg W. Stone
Publikováno v:
European Heart Journal, 31(9), 1071-1078. Oxford University Press
Aims To investigate the clinical impact of the following observations in the randomized SPIRIT II and III trials: an incremental increase in in-stent neointima between 1 and 2 years with the everolimus-eluting stent (EES) but not with the paclitaxel-
Autor:
Julian Benetato Guiran, Gregg W. Stone, Mark Sanz, Ecaterina Cristea, Roseann White, William G. Newman, Halil Mutlu, Xiaolu Su, Poornima Sood, Alexandra J. Lansky, Vivian Ng, Julie Doostzadeh, Sherry Cao, Krishnankutty Sudhir, Mark Midei
Publikováno v:
Catheterization and Cardiovascular Interventions. 74:719-727
Objectives: We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial. Background: The SPIRIT III trial demonstrated superior efficacy of the XIENCE V everolimus-eluting stent compare
Publikováno v:
Toxicological Sciences. 95:182-187
The yeast deletion collection includes approximately 4700 strains deleted for both copies of every nonessential gene. This collection is a powerful resource for identifying the cellular pathways that functionally interact with drugs. In the present s
Autor:
Manejeh Yaqub, Alexandra J. Lansky, Naim Farhat, Krishnankutty Sudhir, Julie Doostzadeh, Donald E. Cutlip, Gregg W. Stone, Shui Yu, Poornima Sood, Ronald P. Caputo, Robert J. Applegate, Jerome Williams, James B. Hermiller
Publikováno v:
The American journal of cardiology. 107(6)
The safety and efficacy of the XIENCE V everolimus-eluting stent (EES) compared to the Taxus Express 2 paclitaxel-eluting stent (PES) has been demonstrated through 2 years in the SPIRIT II and III randomized clinical trials, but limited longer-term d
Autor:
Julie Doostzadeh, James B. Hermiller, Krishnankutty Sudhir, Mark Sanz, Gregg W. Stone, Wesley Pierson, Xiaolu Su, Robert J. Applegate, Alexandra J. Lansky
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 6(4)
AIMS To examine the two year clinical outcomes in dual-vessel disease from the SPIRIT III trial comparing the XIENCE V(r) everolimus-eluting stent (EES) to the TAXUS Express2(tm) paclitaxel-eluting stent (PES). METHODS AND RESULTS From a total of 1,0
Autor:
Sherry Cao, Julie Doostzadeh, Krishnankutty Sudhir, Robert J. Applegate, Xiaolu Su, James B. Hermiller, Charles A. Simonton, Paul C. Gordon, Alexandra J. Lansky, Jerome Williams, Gregg W. Stone
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 76(5)
To evaluate whether an everolimus-eluting stent (EES) with thinner stent struts and polymer results in less periprocedural myonecrosis and adverse outcomes.Higher periprocedural myocardial infarction (MI) rates have been reported with the TAXUS® EXP
Autor:
Poornima Sood, Krishnankutty Sudhir, Julie Doostzadeh, Wesley Pierson, Susan Bezenek, Lee N Clark
Publikováno v:
Coronary artery disease. 21(1)
Although originally the practice of using balloon catheters proved successful in the short term, the long-term prognosis was less promising because of restenosis, which occurred in >or=30% of patients. This prompted the development of new techniques